Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608458200 on February 11, 2007

J. Biol. Chem., Vol. 282, Issue 16, 11676-11686, April 20, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/16/11676    most recent
M608458200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghosh, M.
Right arrow Articles by Leslie, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghosh, M.
Right arrow Articles by Leslie, C. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Function, Activity, and Membrane Targeting of Cytosolic Phospholipase A2{zeta} in Mouse Lung Fibroblasts*Formula

Moumita Ghosh{ddagger}, Robyn Loper{ddagger}, Farideh Ghomashchi§, Dawn E. Tucker{ddagger}, Joseph V. Bonventre, Michael H. Gelb§, and Christina C. Leslie{ddagger}||1

From the {ddagger}Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, the §Departments of Chemistry and Biochemistry, University of Washington, Seattle, Washington 98195, the Renal Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, and the ||Departments of Pathology and Pharmacology, University of Colorado School of Medicine, Aurora, Colorado 80045

Group IVA cytosolic phospholipase A2 (cPLA2{alpha}) initiates eicosanoid production; however, this pathway is not completely ablated in cPLA2{alpha}–/– lung fibroblasts stimulated with A23187 [GenBank] or serum. cPLA2{alpha}+/+ fibroblasts preferentially released arachidonic acid, but A23187 [GenBank] -stimulated cPLA2{alpha}–/– fibroblasts nonspecifically released multiple fatty acids. Arachidonic acid release from cPLA2 {alpha}–/– fibroblasts was inhibited by the cPLA2{alpha} inhibitors pyrrolidine-2 (IC50, 0.03 µM) and Wyeth-1 (IC50, 0.1 µM), implicating another C2 domain-containing group IV PLA2. cPLA2 {alpha}–/– fibroblasts contain cPLA2beta and cPLA2{zeta} but not cPLA2{epsilon} or cPLA2{delta}. Purified cPLA2{zeta} exhibited much higher lysophospholipase and PLA2 activity than cPLA2beta and was potently inhibited by pyrrolidine-2 and Wyeth-1, which did not inhibit cPLA2beta. In contrast to cPLA2beta, cPLA2{zeta} expressed in Sf9 cells mediated A23187 [GenBank] -induced arachidonic acid release, which was inhibited by pyrrolidine-2 and Wyeth-1. cPLA2{zeta} exhibits specific activity, inhibitor sensitivity, and low micromolar calcium dependence similar to cPLA2{alpha} and has been identified as the PLA2 responsible for calcium-induced fatty acid release and prostaglandin E2 production from cPLA2 {alpha}–/– lung fibroblasts. In response to ionomycin, EGFP-cPLA2{zeta} translocated to ruffles and dynamic vesicular structures, whereas EGFP-cPLA2{alpha} translocated to the Golgi and endoplasmic reticulum, suggesting distinct mechanisms of regulation for the two enzymes.


Received for publication, September 4, 2006 , and in revised form, January 19, 2007.

* This work was supported by National Institutes of Health Grants HL61378 and HL34303 (to C. C. L.) and HL50040 (to M. H. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains Supplemental Movie 1.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) DQ888308 [GenBank] and DQ904008 [GenBank] .

1 To whom correspondence should be addressed: Dept. of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1214; Fax: 303-270-2155; E-mail: lesliec{at}njc.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Yuan, R. S. Sidhu, D. V. Kuklev, Y. Kado, M. Wada, I. Song, and W. L. Smith
Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers
J. Biol. Chem., April 10, 2009; 284(15): 10046 - 10055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gubern, J. Casas, M. Barcelo-Torns, D. Barneda, X. de la Rosa, R. Masgrau, F. Picatoste, J. Balsinde, M. A. Balboa, and E. Claro
Group IVA Phospholipase A2 Is Necessary for the Biogenesis of Lipid Droplets
J. Biol. Chem., October 10, 2008; 283(41): 27369 - 27382.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. T. Green, S. K. Orr, and R. P. Bazinet
The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids
J. Lipid Res., May 1, 2008; 49(5): 939 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Cubells, S. V. de Muga, F. Tebar, J. V. Bonventre, J. Balsinde, A. Pol, T. Grewal, and C. Enrich
Annexin A6-induced Inhibition of Cytoplasmic Phospholipase A2 Is Linked to Caveolin-1 Export from the Golgi
J. Biol. Chem., April 11, 2008; 283(15): 10174 - 10183.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Graf, B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Muller, E. Fischer, C. Reichel, et al.
Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice
J. Immunol., March 1, 2008; 180(5): 3457 - 3466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wada, C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al.
Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products
J. Biol. Chem., August 3, 2007; 282(31): 22254 - 22266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement